LONDON: British health services on Tuesday mark the first warning of the Oxford / Astrazeneca vaccine placement against Covid-19, produced and deployed in India as soon as the Covishield.
Brian Pinker, 82, became the first person in the world to receive a rescue vaccine living at the University of Oxford Hospital on January 4, 2021.
Since then, the British National Health Service (NHS) said that around 50 million Astrazeneca vaccines have been given in the UK.
About 2.5 billion doses have also been distributed at a cost of more than 170 countries, including those produced by Serum Institute of India in Pune.
“Supported by Government Funds, Oxford-AstraZeneca Vaccine made in British has played a truly important role in our struggle against Covid-19, saving a lot of life in the UK and throughout the world,” said British Health Secretary Javid, who marked the deployment vaccine warning With a visit to the vaccination center in London.
“The British vaccination and booster program is a leading world but with the rapid spread of Omicron variants, more important than before that people advance for their vaccines and booster to add to your immunity this winter and protect the progress we have made,” he said.
The Ministry of Health and Social Care (DHSC) said it was invested earlier in the Oxford University Vaccine Development Team, supporting their technology since 2016 and their Jab Covid-19 since March 2020 with more than GBP 88 million to help research, develop and produce vaccines.
The UK National Health Research Institute (NIHR) helped recruit thousands of volunteers from all over the United Kingdom for clinical testing phase 3 and supported researchers, which paved the way for approval by independent drugs and the health product regulation agency (MHRA) in December 2020.
“Oxford vaccine -Astrazeneca is an English success story and shows what can be achieved when researchers, scientists and the government work together, “said Maggie Throup UK Vaccine Minister.
“At-cost vaccines have given billions of people around the world way to fight back to this virus,” he said.
More than 133 million Covid-19 vaccinations have been given in the UK since the launch of the Pfizer / Biontech vaccine in December 2020, including around 34 million booster and third dose, securing vital protection against the omicron campaign helped develop the Oxford-AstraZeneca vaccine, has warned that it would not Sustainable or affordable in the long run to continue to force all adults to Covid-19 with Booster and say that vulnerable groups must be identified for additional doses.
“Really not affordable, sustainable or maybe even need to vaccinate everyone on this planet every four to six months,” said Prof.
Pollard to the BBC.
“We haven’t even managed to vaccinate everyone in Africa with one dose so we certainly won’t get to the point where the fourth dose for everyone can be managed …
we might need to have a booster for vulnerable in the population but I think It is not possible that we will have a program that will advance regularly increasing everyone over the age of 12, “he said.
In the current guidelines, for people who are clinically vulnerable to Covid because of the underlying health conditions, the third dose of the vaccine is considered a full course – with the fourth jab given as their booster.